SHPH
Shuttle Pharmaceuticals Inc
NASDAQ: SHPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.68
-7.82% today
Updated 2026-06-05
Market cap
$2.66M
P/E ratio
45.40
P/S ratio
—
EPS (TTM)
$0.01
Dividend yield
—
52W range
$0 – $6
Volume
1.7M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.5
Quality
C3.0
Profitability
D4.7
Valuation
C3/9
Piotroski F-Score
Weak
-10.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.06x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -10.55 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-2.45M
- P/E 45.40x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-5.00M | $-6.59M | $-9.14M | $-11.72M | $-2.15M |
| EPS | — | — | — | — | $0.01 |
| Free cash flow | $-2.71M | $-5.60M | $-7.35M | $-9.48M | $-2.45M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Shuttle Pharmaceuticals Inc trades at $0.68. representing a P/E of 45.40x trailing earnings. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -10.55, it sits in the distress.
Frequently asked questions
What is Shuttle Pharmaceuticals Inc's stock price?
Shuttle Pharmaceuticals Inc (SHPH) trades at $0.68, on a P/E of 45.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Shuttle Pharmaceuticals Inc overvalued?
Shuttle Pharmaceuticals Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Shuttle Pharmaceuticals Inc's Altman Z-Score is -10.55, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-323.38%
Beta1.22
50D MA$0.76
200D MA$1.96
Shares out0.01B
Float0.01B
Short ratio—
Avg volume1.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—